T1	intervention 23 34	alendronate
T2	intervention 39 55	calcitriol agent
T3	ethinicity 72 78	Korean
T4	condition 609 629	AI-induced bone loss
T5	duration 704 711	24-week
T6	No-of-participants 823 825	98
T7	eligibility 826 874	Korean postmenopausal women with HR-positive EBC
T8	control 1007 1014	placebo
T9	outcome-Measure 1027 1053	bone mineral density (BMD)
T10	outcome-Measure 1058 1074	turnover markers
T11	outcome 1106 1130	difference in lumbar BMD
T12	outcome 1176 1201	increase in C-telopeptide
